Author

C. Garren Hester

Duke University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

Catherine Bowes RickmaniD· 1 shared Christopher R. StarriD· 1 shared Daniel Grigsby· 1 shared Edward J. Flynn· 1 shared John G. FlanneryiD· 1 shared Joshua AmasoniD· 1 shared Lindsey A. ChewiD· 1 shared Meike ViseliD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Catherine Bowes RickmanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Truncated Complement Factor H Y402 Gene Therapy Cures C3 Glomerulonephritis

Lindsey A. Chew, Daniel Grigsby, C. Garren Hester, Joshua Amason, W. Kyle McPherson, Edward J. Flynn, Meike Visel, Christopher R. Starr, John G. Flannery, Tylor R. Lewis, Catherine Bowes Rickman

This study shows that AAV-delivered truncated CFH gene therapy can reverse C3G in mice and suggests its potential for treating AMD.

Molecular Therapy · Apr 24, 2025Peer-reviewedPathology